Congressman Cohen Announces UTHSC Cancer Therapy Grant

April 11, 2018
Press Release

WASHINGTON – Congressman Steve Cohen (TN-09) today announced that the National Cancer Institute (NCI) has awarded a federal research grant totaling nearly $300,000 to the University of Tennessee Health Science Center (UTHSC). These funds will help support UTHSC research to identify potential new drugs in cancer therapies through their Anticancer Strategies Targeting the Autotaxin-LPA Receptor Axis program.

“Memphis is fortunate to be the home of the UT Health Science Center, which is known nationwide for its accomplishments in medical research,” said Congressman Cohen. “These new federal funds will provide UTHSC with the support it needs to continue its cancer treatment research and help Memphians, Tennesseans and all Americans to fight cancer.”

The NCI was established by Congress in 1937 and is part of the National Institutes of Health, one of the eleven agencies that compose the Department of Health and Human Services (HHS). HHS allocates millions of dollars for medical research each year through its various institutes and research centers. The NCI is the Federal Government’s principal agency for cancer research and training. This most recent grant allocation from NCI brings the total amount of federal dollars awarded to UTHSC for medical research in 2018 to more than $2,000,000.